A clinical stage company developing a breakthrough artificial heart valve
Novostia has raised €2.5M across 1 funding round, most recently a Series B round in May 2023. Based in Lausanne, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-05-03 | Series B | €2.5M |
| — |
| View deal → |
